Intervention effect and dose-dependent response of Tanreqing injection on airway inflammation in lipopolysaccharide-induced rats

被引:16
作者
Dong, Shoujin [1 ]
Zhong, Yunqing [2 ]
Yang, Kun [3 ]
Xiong, Xiaoling [4 ]
Mao, Bing [1 ]
机构
[1] Sichuan Univ, Pneumol Grp, Dept Integrated Tradit Chinese & Western Med, West China Hosp,West China Sch Med, Chengdu 610041, Peoples R China
[2] Guangxi Tradit Chinese Med Univ, Dept Resp Med, Affiliated Hosp 1, Nanning 530023, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Dept Geratol, Chengdu 610041, Peoples R China
[4] Sichuan Hosp Integrated Tradit Chinese & Western, Dept Geratol, Chengdu 610041, Peoples R China
关键词
Pulmonary disease; chronic obstructive; Lipopolysaccharides; Dose-response relationship; drug; Airway inflammation; Tanreqing injection; OBSTRUCTIVE PULMONARY-DISEASE; INTERLEUKIN-8; FAMILY; INDUCED SPUTUM; LUNG INFLAMMATION; ANIMAL-MODELS; MEMBER; EXPRESSION; ENDOTOXIN; CINC; LPS;
D O I
10.1016/S0254-6272(13)60156-9
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To as sess the effect of Tanreqing injection on airway inflammation in rats. METHODS: A rat model of airway inflammation was generated with lipopolysaccharide (LPS). Tanreqing injection was given by intratracheal instillation, and bronchoalveolar lavage fluid (BALF) from the right lung was collected. BALE total cell and neutrophil counts were then determined. In addition, BALE levels of inflammatory cytokines interleukin-1 beta, cytokine-induced neutrophil chennoattractant-1, and tumor necrosis factor-alpha were measured using enzyme linked immunosorbent assay. The middle lobe of the right lung was stained with hematoxylin-eosin and histological changes examined. RESULTS: LPS increased airway inflammation, decreased BALF inflammatory cell count, inflammatory cytokine levels, and suppressed leukocyte influx of the lung. The LPS-induced airway inflammation peaked at 24 h, decreased beginning at 48 h, and had decreased markedly by 96 h. CONCLUSION: Tanreqing injection contains anti-inflammatory properties, and inhibits airway inflammation in a dose-dependent manner. (C) 2013 JTCM. All rights reserved.
引用
收藏
页码:505 / 512
页数:8
相关论文
共 38 条
  • [1] Clava cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration
    Arsalane, K
    Broeckaert, F
    Knoops, B
    Wiedig, M
    Toubeau, G
    Bernard, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) : 1624 - 1630
  • [2] Mediators of chronic obstructive pulmonary disease
    Barnes, PJ
    [J]. PHARMACOLOGICAL REVIEWS, 2004, 56 (04) : 515 - 548
  • [3] New concepts in chronic obstructive pulmonary disease
    Barnes, PJ
    [J]. ANNUAL REVIEW OF MEDICINE, 2003, 54 : 113 - 129
  • [4] Bishop Russell E., 2005, V12, P1, DOI 10.1159/000081687
  • [5] Cytokines in chronic obstructive pulmonary disease
    Chung, KF
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 18 : 50S - 59S
  • [6] Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806
  • [7] Discrete Fixed Points: Models, Complexities, and Applications
    Deng, Xiaotie
    Qi, Qi
    Saberi, Amin
    Zhang, Jie
    [J]. MATHEMATICS OF OPERATIONS RESEARCH, 2011, 36 (04) : 636 - 652
  • [8] Role of interleukin-8 in the pathogenesis and treatment of COPD
    Di Stefano, A
    Capelli, A
    Donner, CF
    [J]. CHEST, 2004, 126 (03) : 676 - 678
  • [9] Severity of airflow limitation is associated with severity of airway inflammation in smokers
    Di Stefano, A
    Capelli, A
    Lusuardi, M
    Balbo, P
    Vecchio, C
    Maestrelli, P
    Mapp, CE
    Fabbri, LM
    Donner, CF
    Saetta, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) : 1277 - 1285
  • [10] Gan WQ, 2005, BMC PULM MED, V5, P1